Agata Chrzanowska

Research Officer

Agata joined National Drug and Alcohol Research Centre (NDARC) as a Research Officer in December 2018.

Public health is her passion and she is always dedicated to deliver the highest quality work. She is currently working with hospital and treatment administrative databases across Drug Trends and Social Costs projects undertaking data management and data analyses.

Agata completed a Master in Biostatistics at The University of Sydney in 2018. She has five years experience in data science working on several independent projects in different areas of research.  

publications

Reports
add
Chrzanowska A; Dobbins T; Degenhardt L; Peacock A, 2019, Trends in Drug-Induced Deaths in Australia, 1997-2017, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Trends Bulletin Series, https://ndarc.med.unsw.edu.au/resource/trends-drug-induced-deaths-australia-1997-2017
2019
Man N; Chrzanowska A; Dobbins T; Degenhardt L; Peacock A, 2019, Trends in drug-induced deaths in Australia, 1997-2018, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5de99b7b91694, http://handle.unsw.edu.au/1959.4/unsworks_62965
2019
Chrzanowska A; Man N; Degenhardt L; Dobbins T; Peacock A, 2019, Trends in drug-related hospital separations in Australia, 1999-2018, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5de99a8cd771f, http://handle.unsw.edu.au/1959.4/unsworks_62971
2019
Journal articles
add
Nair-Shalliker V; Egger S; Chrzanowska A; Mason R; Waite L; Le Couteur D; Seibel MJ; Handelsman DJ; Cumming R; Smith DP; Armstrong BK, 2018, 'Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels', PLOS ONE, vol. 13, http://dx.doi.org/10.1371/journal.pone.0193893
2018
van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G, 2017, 'Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study', LANCET ONCOLOGY, vol. 18, pp. 1386 - 1396, http://dx.doi.org/10.1016/S1470-2045(17)30621-6
2017